
News
Filter Results
Displaying 31–40 of 495
-
Aug 14, 2024
The four-year study will inform clinical trial design for emerging USH3 therapies.
-
Jul 30, 2024
AREDS Formula Reduces Risk of Visual Acuity Loss for People with Geographic Atrophy
Previously, the formula was thought to only reduce risk of early age-related macular degeneration advancing to late-stage disease
-
Jul 8, 2024
Genentech to Re-Introduce Susvimo for Wet AMD
FDA-approved in 2021, the tiny implantable capsule provides sustained delivery of treatment, but was recalled in 2022.
-
Jun 27, 2024
Karen Petrou Appointed as Board Chair of the Foundation Fighting Blindness
David Brint retires after eight years of distinguished service; Petrou to lead effective July 1, 2024.
-
Jun 13, 2024
Beacon Doses First Patient in its Phase 2/3 VISTA Clinical Trial for XLRP Gene Therapy
The company plans to apply for regulatory approval for the gene therapy with data from VISTA and its earlier clinical trials.
-
Jun 5, 2024
Antabuse Moves into Clinical Trial for People with RP
Researchers believe the FDA-approved drug can reduce the hyperactivity of ganglion cells to improve vision.
-
May 22, 2024
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease
-
May 22, 2024
Advancing Research Solutions for PRPH2-Associated Retinal Diseases.
-
May 17, 2024
Foundation Fighting Blindness to Host VISIONS 2024 Conference
The global conference, held on June 21–22, is dedicated to fostering connection, learning, and empowerment for individuals and families impacted by blinding diseases.
-
May 16, 2024
No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.